Third Party Relationship Records and Due Diligence
October 01, 2020
Third Party Relationship Records and Due Diligence

Score 7 out of 10
Vetted Review
Verified User
Overall Satisfaction with RSA Archer
The whole organization uses RSA Archer across multiple subsidiaries to document relationships, risks, assets and controls. It effectively links issues to vendor relationships and assets while automating assessments within workflows. The dashboard capability allows for a wide range of customization for multiple types of users, offering a rich KPI experience.
- RSA Archer provides robust ad-hoc reporting.
- RSA Archer provides very detailed control over workflows and their customization.
- RSA Archer provides multiple systems for the different needs of corporate governance.
- RSA Archer scripts run particularly slow.
- RSA Archer doesn't leverage calculated fields efficiently.
- RSA Archer doesn't have pop-up windows or peek windows into hyperlinks.
- RSA Archer has been a great asset in demonstrating compliance to regulators
- RSA Archer provides whole company coverage, no management of 'seats'
- RSA Archer has unified all Risk and Compliance team reviews for a cohesive risk outlook.
Microsoft Dynamics is a useful tool with easy integration to toolsets for analytics, and has a remarkable ease of use. The accessibility and discoverability in RSA Archer is more difficult, as sections get densely nested. The search capability in Dynamics is smoother but reliant on complete words being used, whereas RSA Archer searching is full Boolean.
Do you think Archer Integrated Risk Management Platform delivers good value for the price?
Yes
Are you happy with Archer Integrated Risk Management Platform's feature set?
Yes
Did Archer Integrated Risk Management Platform live up to sales and marketing promises?
I wasn't involved with the selection/purchase process
Did implementation of Archer Integrated Risk Management Platform go as expected?
I wasn't involved with the implementation phase
Would you buy Archer Integrated Risk Management Platform again?
Yes